HCA Healthcare, Inc. (HCA)
NYSE: HCA · IEX Real-Time Price · USD
306.69
-7.43 (-2.37%)
At close: Apr 26, 2024, 4:00 PM
310.00
+3.31 (1.08%)
After-hours: Apr 26, 2024, 7:21 PM EDT
HCA Healthcare Revenue
In the year 2023, HCA Healthcare had annual revenue of $64.97B with 7.86% growth. Revenue in the quarter ending December 31, 2023 was $17.30B with 11.65% year-over-year growth.
Revenue (ttm)
$64.97B
Revenue Growth
+7.86%
P/S Ratio
1.25
Revenue / Employee
$209,574
Employees
310,000
Market Cap
81.11B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 64.97B | 4.74B | 7.86% |
Dec 31, 2022 | 60.23B | 1.48B | 2.52% |
Dec 31, 2021 | 58.75B | 7.22B | 14.01% |
Dec 31, 2020 | 51.53B | 197.00M | 0.38% |
Dec 31, 2019 | 51.34B | 4.66B | 9.98% |
Dec 31, 2018 | 46.68B | 3.06B | 7.02% |
Dec 31, 2017 | 43.61B | 2.12B | 5.12% |
Dec 31, 2016 | 41.49B | 1.81B | 4.57% |
Dec 31, 2015 | 39.68B | 2.76B | 7.48% |
Dec 31, 2014 | 36.92B | 2.74B | 8.00% |
Dec 31, 2013 | 34.18B | 1.17B | 3.54% |
Dec 31, 2012 | 33.01B | 3.33B | 11.22% |
Dec 31, 2011 | 29.68B | 1.65B | 5.87% |
Dec 31, 2010 | 28.04B | 1.26B | 4.70% |
Dec 31, 2009 | 26.78B | -1.60B | -5.63% |
Dec 31, 2008 | 28.37B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CVS Health | 357.78B |
McKesson | 301.51B |
Cigna | 195.27B |
Bristol-Myers Squibb Company | 45.01B |
GSK | 38.39B |
Gilead Sciences | 27.12B |
Becton, Dickinson and Company | 19.49B |
Regeneron Pharmaceuticals | 13.12B |
HCA News
- 19 hours ago - HCA beats first-quarter profit estimates on higher patient admissions - Reuters
- 19 hours ago - HCA Healthcare Reports First Quarter 2024 Results - Business Wire
- 2 days ago - Best blue chip healthcare stocks to buy and hold in 2024 - Invezz
- 3 days ago - Clinical Trial by Harvard Pilgrim Health Care Institute, HCA Healthcare, UCI Health and CDC Identifies Strategy to Rapidly Detect and Respond to Hospital Outbreaks Using Algorithm-Driven Technology - Business Wire
- 4 days ago - Fortune Names HCA Healthcare One of the World's Most Admired Companies - Business Wire
- 7 days ago - Two Clinical Trials Identify a Better Way to Target Appropriate Antibiotics for Patients Hospitalized With Pneumonia or Urinary Tract Infection - Business Wire
- 23 days ago - HCA Healthcare, Inc. to Present at May Healthcare Conferences - Business Wire
- 4 weeks ago - HCA Healthcare Releases 2024 Annual Impact Report - Business Wire